Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,175) with videos related to
Page
of 118
Sort By:
The Journal of Urology
|
April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study
Michael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
The Prostate
|
May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Dean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Heliyon
|
February 7, 2023
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
B Ffrench, E Kashdan, Y Huang, et al.
Prostate Cancer and Prostatic Diseases
|
July 20, 2016
A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment
M A Liss, J M Schenk, A V Faino, et al.
The Journal of Urology
|
December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort
Adrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
March 5, 2025
Seven years of CRAFT: Clinical results of a multicenter cohort of carotid artery relining with the CASPER RX stent
Ariel Dahan, Siddharth M Kulkarni, Calvin Gan, et al.
CA: a Cancer Journal for Clinicians
|
June 12, 2014
American Cancer Society prostate cancer survivorship care guidelines
Ted A Skolarus, Andrew M D Wolf, Nicole L Erb, et al.
Human Mutation
|
September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Jennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.
The Lancet. Oncology
|
September 7, 2013
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
Stephen E Jones, Rufus Collea, Devchand Paul, et al.
The Journal of Urology
|
October 26, 2019
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study
Jeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Page
of 118
Search research articles
Search
Showing results (1091-1100 of 1,175) with videos related to
Sort By:
Page
of 118
The Journal of Urology
|
April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study
Michael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
The Prostate
|
May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Dean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Heliyon
|
February 7, 2023
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
B Ffrench, E Kashdan, Y Huang, et al.
Prostate Cancer and Prostatic Diseases
|
July 20, 2016
A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment
M A Liss, J M Schenk, A V Faino, et al.
The Journal of Urology
|
December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort
Adrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
March 5, 2025
Seven years of CRAFT: Clinical results of a multicenter cohort of carotid artery relining with the CASPER RX stent
Ariel Dahan, Siddharth M Kulkarni, Calvin Gan, et al.
CA: a Cancer Journal for Clinicians
|
June 12, 2014
American Cancer Society prostate cancer survivorship care guidelines
Ted A Skolarus, Andrew M D Wolf, Nicole L Erb, et al.
Human Mutation
|
September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Jennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.
The Lancet. Oncology
|
September 7, 2013
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
Stephen E Jones, Rufus Collea, Devchand Paul, et al.
The Journal of Urology
|
October 26, 2019
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study
Jeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Page
of 118